Last reviewed · How we verify

NCT04507451

Respiratory Muscle Training in ICU Patients

Status unknown NA Last updated 4 November 2020
What this trial tests

NA trial testing inspiratory and expiratory muscle training in Critical Illness in 100 participants. Status unknown.

Timeline
1 October 2020
Primary endpoint
1 September 2023
1 September 2023

Quick facts

Lead sponsorUniversity of Liege
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment100
Start date1 October 2020
Primary completion1 September 2023
Estimated completion1 September 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University of Liege

Who can join

18 and older, male only, with Critical Illness or Inspiratory Muscle Strength. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Respiratory muscle weakness is common after mechanical ventilation and occurs early. This can limit functional recovery. Respiratory muscle training is often neglected in clinical practice. Some data indicates that inspiratory muscle training increases inspiratory muscle strength and quality of life. The aim of the study is to assess the impact of combined inspiratory and expiratory muscle training on inspiratory muscle strength. The second aim is to assess the impact of this training program on expiratory muscle strength.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other University of Liege trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04507451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing